Pharmacy News

Image description

Sandoz introduces generic Pulmicort Respules

Sandoz on Tuesday announced the launch of a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) in 1-mg strength. Sandoz expects to have 180-day generic drug marketing exclusivity for the 1-mg strength.

Image description

NACDS Total Store Expo exhibit hall sold out

The National Association of Chain Drug Stores today announced that the Exhibit Hall for the 2015 NACDS Total Store Expo, which will take place from Aug. 22 to 25 at the Colorado Convention Center in Denver, is sold out.

Image description

Novartis gets FDA approval for Odomzo

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

Image description

FDA approves Technivie for chronic hepatitis C treatment

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.